NVAX logo

Novavax, Inc. (NVAX) EBIT

Annual EBIT:

-$231.97M+$183.06M(+44.11%)
December 31, 2024

Summary

  • As of today, NVAX annual earnings before interest & taxes is -$231.97 million, with the most recent change of +$183.06 million (+44.11%) on December 31, 2024.
  • During the last 3 years, NVAX annual EBIT has risen by +$1.45 billion (+86.25%).
  • NVAX annual EBIT is now -4980.38% below its all-time high of -$4.57 million, reached on December 31, 1999.

Performance

NVAX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

Quarterly EBIT:

$112.97M-$412.60M(-78.50%)
June 30, 2025

Summary

  • As of today, NVAX quarterly earnings before interest & taxes is $112.97 million, with the most recent change of -$412.60 million (-78.50%) on June 30, 2025.
  • Over the past year, NVAX quarterly EBIT has dropped by -$55.76 million (-33.05%).
  • NVAX quarterly EBIT is now -78.50% below its all-time high of $525.57 million, reached on March 31, 2025.

Performance

NVAX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

TTM EBIT:

$454.45M-$55.76M(-10.93%)
June 30, 2025

Summary

  • As of today, NVAX TTM earnings before interest & taxes is $454.45 million, with the most recent change of -$55.76 million (-10.93%) on June 30, 2025.
  • Over the past year, NVAX TTM EBIT has increased by +$728.10 million (+266.07%).
  • NVAX TTM EBIT is now -10.93% below its all-time high of $510.21 million, reached on March 31, 2025.

Performance

NVAX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

NVAX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+44.1%-33.0%+266.1%
3Y3 Years+86.3%+122.5%+131.8%
5Y5 Years-79.0%+880.5%+275.5%

NVAX EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+86.3%-78.5%+139.2%-10.9%+135.6%
5Y5-Year-79.0%+86.3%-78.5%+113.7%-10.9%+126.8%
All-TimeAll-Time-4980.4%+86.3%-78.5%+113.7%-10.9%+126.8%

NVAX EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
$112.97M(-78.5%)
$454.45M(-10.9%)
Mar 2025
-
$525.57M(+896.4%)
$510.21M(+425.9%)
Dec 2024
-$231.97M(+44.1%)
-$66.00M(+44.1%)
-$156.54M(+40.5%)
Sep 2024
-
-$118.10M(-170.0%)
-$263.13M(+3.8%)
Jun 2024
-
$168.73M(+219.5%)
-$273.65M(+28.2%)
Mar 2024
-
-$141.18M(+18.2%)
-$381.39M(+27.9%)
Dec 2023
-$415.03M(+35.6%)
-$172.58M(-34.2%)
-$528.62M(+1.4%)
Sep 2023
-
-$128.61M(-310.9%)
-$535.94M(+5.9%)
Jun 2023
-
$60.99M(+121.1%)
-$569.30M(+49.8%)
Mar 2023
-
-$288.41M(-60.3%)
-$1.13B(-78.8%)
Dec 2022
-$644.74M(+61.8%)
-$179.91M(-11.1%)
-$633.77M(+50.4%)
Sep 2022
-
-$161.97M(+67.8%)
-$1.28B(+10.5%)
Jun 2022
-
-$502.83M(-338.4%)
-$1.43B(-12.6%)
Mar 2022
-
$210.95M(+125.6%)
-$1.27B(+25.2%)
Dec 2021
-$1.69B(-307.4%)
-$824.54M(-164.9%)
-$1.69B(-62.4%)
Sep 2021
-
-$311.21M(+9.2%)
-$1.04B(-12.8%)
Jun 2021
-
-$342.80M(-59.3%)
-$924.55M(-55.1%)
Mar 2021
-
-$215.22M(-23.9%)
-$596.23M(-47.6%)
Dec 2020
-$414.02M(-219.5%)
-$173.69M(+9.9%)
-$403.83M(-56.0%)
Sep 2020
-
-$192.85M(-1232.4%)
-$258.92M(-219.4%)
Jun 2020
-
-$14.47M(+36.6%)
-$81.07M(+21.4%)
Mar 2020
-
-$22.82M(+20.7%)
-$103.15M(+14.4%)
Dec 2019
-$129.60M(+25.5%)
-$28.78M(-91.9%)
-$120.51M(+12.7%)
Sep 2019
-
-$15.00M(+59.0%)
-$138.01M(+16.1%)
Jun 2019
-
-$36.56M(+9.0%)
-$164.54M(+2.9%)
Mar 2019
-
-$40.17M(+13.2%)
-$169.43M(+1.8%)
Dec 2018
-$173.92M(-1.3%)
-$46.29M(-11.5%)
-$172.56M(+0.6%)
Sep 2018
-
-$41.52M(-0.2%)
-$173.59M(-0.3%)
Jun 2018
-
-$41.45M(+4.3%)
-$173.16M(-0.3%)
Mar 2018
-
-$43.30M(+8.5%)
-$172.66M(-1.7%)
Dec 2017
-$171.71M(+36.2%)
-$47.32M(-15.2%)
-$169.70M(+3.6%)
Sep 2017
-
-$41.09M(-0.3%)
-$175.98M(+11.0%)
Jun 2017
-
-$40.95M(-1.5%)
-$197.63M(+15.0%)
Mar 2017
-
-$40.34M(+24.7%)
-$232.52M(+12.9%)
Dec 2016
-$269.11M(-71.2%)
-$53.60M(+14.6%)
-$267.00M(+8.6%)
Sep 2016
-
-$62.74M(+17.3%)
-$292.10M(-11.3%)
Jun 2016
-
-$75.84M(-1.4%)
-$262.41M(-26.7%)
Mar 2016
-
-$74.82M(+4.9%)
-$207.18M(-32.2%)
Dec 2015
-$157.24M(-87.9%)
-$78.69M(-138.1%)
-$156.70M(-43.0%)
Sep 2015
-
-$33.06M(-60.3%)
-$109.54M(-13.9%)
Jun 2015
-
-$20.61M(+15.3%)
-$96.17M(-3.0%)
Mar 2015
-
-$24.33M(+22.8%)
-$93.37M(-12.8%)
Dec 2014
-$83.69M(-63.7%)
-$31.54M(-60.3%)
-$82.79M(-26.8%)
Sep 2014
-
-$19.68M(-10.5%)
-$65.27M(-7.3%)
Jun 2014
-
-$17.81M(-29.5%)
-$60.83M(-9.4%)
Mar 2014
-
-$13.76M(+1.9%)
-$55.60M(-7.3%)
Dec 2013
-$51.13M(-72.4%)
-$14.02M(+8.0%)
-$51.80M(-13.1%)
Sep 2013
-
-$15.24M(-21.1%)
-$45.79M(-21.2%)
Jun 2013
-
-$12.58M(-26.4%)
-$37.77M(-21.4%)
Mar 2013
-
-$9.96M(-24.2%)
-$31.10M(-9.2%)
Dec 2012
-$29.66M(-37.5%)
-$8.02M(-11.1%)
-$28.48M(-17.8%)
Sep 2012
-
-$7.21M(-21.9%)
-$24.16M(-19.8%)
Jun 2012
-
-$5.92M(+19.3%)
-$20.16M(-7.1%)
Mar 2012
-
-$7.33M(-98.1%)
-$18.82M(+0.6%)
Dec 2011
-$21.58M(+43.9%)
-$3.70M(-15.3%)
-$18.94M(+13.3%)
Sep 2011
-
-$3.21M(+29.9%)
-$21.84M(+24.7%)
Jun 2011
-
-$4.58M(+38.5%)
-$28.98M(+12.9%)
Mar 2011
-
-$7.45M(-13.0%)
-$33.26M(+10.7%)
Dec 2010
-$38.49M
-$6.60M(+36.3%)
-$37.26M(+20.7%)
DateAnnualQuarterlyTTM
Sep 2010
-
-$10.36M(-17.0%)
-$47.00M(-4.7%)
Jun 2010
-
-$8.86M(+22.7%)
-$44.90M(-2.3%)
Mar 2010
-
-$11.45M(+29.9%)
-$43.88M(-10.9%)
Dec 2009
-$37.38M(-8.8%)
-$16.33M(-97.7%)
-$39.56M(-22.0%)
Sep 2009
-
-$8.26M(-5.5%)
-$32.44M(+4.3%)
Jun 2009
-
-$7.83M(-9.7%)
-$33.90M(+1.1%)
Mar 2009
-
-$7.14M(+22.5%)
-$34.28M(+0.2%)
Dec 2008
-$34.36M(-13.5%)
-$9.21M(+5.3%)
-$34.36M(-20.8%)
Sep 2008
-
-$9.73M(-18.6%)
-$28.45M(-1.7%)
Jun 2008
-
-$8.20M(-13.6%)
-$27.98M(+1.8%)
Mar 2008
-
-$7.22M(-119.1%)
-$28.50M(+2.1%)
Dec 2007
-$30.27M(-23.0%)
-$3.30M(+64.4%)
-$29.12M(+0.2%)
Sep 2007
-
-$9.26M(-6.1%)
-$29.17M(-13.9%)
Jun 2007
-
-$8.72M(-11.3%)
-$25.61M(-7.1%)
Mar 2007
-
-$7.84M(-134.1%)
-$23.92M(-13.3%)
Dec 2006
-$24.61M(-25.6%)
-$3.35M(+41.2%)
-$21.12M(-240.4%)
Sep 2006
-
-$5.69M(+19.1%)
-$6.20M(-125.8%)
Jun 2006
-
-$7.04M(-39.8%)
-$2.75M(-194.1%)
Mar 2006
-
-$5.04M(-143.5%)
-$934.00K(+78.4%)
Dec 2005
-$19.59M(+43.9%)
$11.56M(+616.9%)
-$4.32M(+83.3%)
Sep 2005
-
-$2.24M(+57.2%)
-$25.79M(+0.3%)
Jun 2005
-
-$5.22M(+37.9%)
-$25.87M(+7.6%)
Mar 2005
-
-$8.42M(+15.0%)
-$27.98M(-14.4%)
Dec 2004
-$34.90M(-117.4%)
-$9.91M(-327.1%)
-$24.46M(-38.9%)
Sep 2004
-
-$2.32M(+68.4%)
-$17.62M(+3.5%)
Jun 2004
-
-$7.34M(-49.9%)
-$18.26M(-17.4%)
Mar 2004
-
-$4.90M(-60.0%)
-$15.55M(+3.1%)
Dec 2003
-$16.05M(+25.5%)
-$3.06M(-3.4%)
-$16.05M(+6.0%)
Sep 2003
-
-$2.96M(+36.1%)
-$17.09M(+17.1%)
Jun 2003
-
-$4.63M(+14.2%)
-$20.60M(+4.1%)
Mar 2003
-
-$5.40M(-32.0%)
-$21.49M(+0.3%)
Dec 2002
-$21.56M(-61.1%)
-$4.09M(+36.8%)
-$21.56M(-5.1%)
Sep 2002
-
-$6.48M(-17.5%)
-$20.52M(-25.0%)
Jun 2002
-
-$5.51M(-0.7%)
-$16.41M(-30.5%)
Mar 2002
-
-$5.47M(-79.6%)
-$12.58M(-35.9%)
Dec 2001
-$13.38M(-5.0%)
-$3.05M(-28.5%)
-$9.26M(+18.0%)
Sep 2001
-
-$2.37M(-41.0%)
-$11.29M(+8.2%)
Jun 2001
-
-$1.68M(+21.9%)
-$12.29M(+8.5%)
Mar 2001
-
-$2.15M(+57.7%)
-$13.44M(-5.5%)
Dec 2000
-$12.74M(-179.1%)
-$5.08M(-50.6%)
-$12.74M(-45.5%)
Sep 2000
-
-$3.38M(-19.4%)
-$8.76M(-21.9%)
Jun 2000
-
-$2.83M(-94.3%)
-$7.18M(-39.3%)
Mar 2000
-
-$1.46M(-32.3%)
-$5.16M(-12.1%)
Dec 1999
-$4.57M(+11.4%)
-$1.10M(+38.9%)
-$4.60M(+11.5%)
Sep 1999
-
-$1.80M(-125.0%)
-$5.20M(-10.6%)
Jun 1999
-
-$800.00K(+11.1%)
-$4.70M(+9.6%)
Mar 1999
-
-$900.00K(+47.1%)
-$5.20M(0.0%)
Dec 1998
-$5.15M(-7.5%)
-$1.70M(-30.8%)
-$5.20M(-13.0%)
Sep 1998
-
-$1.30M(0.0%)
-$4.60M(-2.2%)
Jun 1998
-
-$1.30M(-44.4%)
-$4.50M(0.0%)
Mar 1998
-
-$900.00K(+18.2%)
-$4.50M(+4.3%)
Dec 1997
-$4.79M(+13.4%)
-$1.10M(+8.3%)
-$4.70M(+13.0%)
Sep 1997
-
-$1.20M(+7.7%)
-$5.40M(-3.8%)
Jun 1997
-
-$1.30M(-18.2%)
-$5.20M(0.0%)
Mar 1997
-
-$1.10M(+38.9%)
-$5.20M(0.0%)
Dec 1996
-$5.53M(+17.9%)
-$1.80M(-80.0%)
-$5.20M(-52.9%)
Sep 1996
-
-$1.00M(+23.1%)
-$3.40M(-41.7%)
Jun 1996
-
-$1.30M(-18.2%)
-$2.40M(-118.2%)
Mar 1996
-
-$1.10M
-$1.10M
Dec 1995
-$6.74M
-
-

FAQ

  • What is Novavax, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Novavax, Inc.?
  • What is Novavax, Inc. annual EBIT year-on-year change?
  • What is Novavax, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Novavax, Inc.?
  • What is Novavax, Inc. quarterly EBIT year-on-year change?
  • What is Novavax, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Novavax, Inc.?
  • What is Novavax, Inc. TTM EBIT year-on-year change?

What is Novavax, Inc. annual earnings before interest & taxes?

The current annual EBIT of NVAX is -$231.97M

What is the all-time high annual EBIT for Novavax, Inc.?

Novavax, Inc. all-time high annual earnings before interest & taxes is -$4.57M

What is Novavax, Inc. annual EBIT year-on-year change?

Over the past year, NVAX annual earnings before interest & taxes has changed by +$183.06M (+44.11%)

What is Novavax, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of NVAX is $112.97M

What is the all-time high quarterly EBIT for Novavax, Inc.?

Novavax, Inc. all-time high quarterly earnings before interest & taxes is $525.57M

What is Novavax, Inc. quarterly EBIT year-on-year change?

Over the past year, NVAX quarterly earnings before interest & taxes has changed by -$55.76M (-33.05%)

What is Novavax, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of NVAX is $454.45M

What is the all-time high TTM EBIT for Novavax, Inc.?

Novavax, Inc. all-time high TTM earnings before interest & taxes is $510.21M

What is Novavax, Inc. TTM EBIT year-on-year change?

Over the past year, NVAX TTM earnings before interest & taxes has changed by +$728.10M (+266.07%)
On this page